Mixed Incontinence: Medical Or Surgical Approach?

Stopped early · Phase 4

Conditions studied: Urinary Incontinence

In brief

The purpose of this study is to compare treatment outcomes for patients with mixed urinary incontinence (MUI) for whom therapy is initiated with surgery to those for whom therapy is initiated with non-surgical treatment. Women who are bothered by symptoms of both stress and urge incontinence will be randomly assigned to initiate treatment with a surgical (surgery for stress incontinence) vs. a non-surgical (drug and behavioral therapy) approach. Follow-up will be a minimum of 12 Months.

Key facts

Study ID

NCT00803270

Run by

Carelon Research

People needed

27

Starts

2008-10-01

Expected to finish

2009-03-01

Last updated by the study team

2013-05-10

Who can join

Age: 21 and older. Sex: female. Healthy volunteers: accepted.

You may qualify if…

• Female
• Mixed UI as evidenced by stress and urge symptoms reported on MESA (either percent of urge-type symptoms ≥ the percent of stress-type symptoms or urge symptom score ≥7 if stress predominant) followed by report of "moderately" or "greatly"/"quite a bit" bothered to questions 2 and 3 of the 6-item Urinary Distress Index (UDI-6) or questions 16 and 17 of the 20-item Pelvic Fl;oor Distress Index (PFDI-20), respectively (See Appendix C)
• Moderate or severe UI as evidenced by the corresponding response on the Patient Global Impression of Severity (PGI-S)
• Incontinence symptoms present for at least (3) months*
• Bladder capacity > 200cc (by any method)
• Urodynamic Stress Incontinence
• Eligible for both treatment interventions
• Available to start intervention within 6 weeks
• Negative urine dipstick (negative result = trace or less for leukocytes \& nitrites)
• Available for 12 months of follow-up and able to complete study assessments as per clinician judgment
• Signed consent form

You may not qualify if…

• Age <21 years*
• Currently undergoing or recommended to undergo treatment of pelvic organ prolapse
• Other indicated/planned concomitant surgery
• Pregnant or has not completed child bearing*
• <12 months post-partum*†
• Active malignancy of cervix, uterus, fallopian tube(s) or ovary > Stage I, or bladder of any Stage
• Current catheter use
• Unevaluated hematuria
• Participation in another trial that may influence the results of this study
• Patient can be rescreened after respective time interval has been met. †"Partum" is defined as a delivery or other termination that occurs after 20 weeks gestation.

Where it is running

• University of Alabama — Birmingham, Alabama, United States
• University of California — San Diego, California, United States
• Loyola University Medical Center — Maywood, Illinois, United States
• University of Maryland — Baltimore, Maryland, United States
• Oakwood Hospital/Cancer Center — Dearborn, Michigan, United States
• Beaumont Hospital — Royal Oak, Michigan, United States
• University of Pittsburgh — Pittsburgh, Pennsylvania, United States
• University of Texas Southwestern — Dallas, Texas, United States
• University of Texas Health Sciences Center — San Antonio, Texas, United States
• University of Utah — Salt Lake City, Utah, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.